INTEC PHARMA LTD. Asset Impairment Charges
INTEC PHARMA LTD. reported Asset Impairment Charges of $13.66 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2021-03-16
- INTEC PHARMA LTD. asset impairment charges for the quarter ending 2019-12-31 was $3.90M.
- INTEC PHARMA LTD. asset impairment charges for the quarter ending 2019-09-30 was $9.76M.
- INTEC PHARMA LTD. asset impairment charges for fiscal 2019 was $13.66M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 9 month as first filed | Asset Impairment Charges 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $13.66M derived: sum of 2 quarters · filed 2021-03-16 | $13.66M 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $9.76M 10-Q · filed 2020-11-05 | $9.76M 10-Q · filed 2020-11-05 | $9.80M 10-Q · filed 2019-11-12 |